Showing 1861-1880 of 7110 for: Cochrane Systematic Reviews Back
- Dressings for healing venous leg ulcers
Cochrane Systematic Reviews, 6-May-2014
Venous leg ulcers, sometimes called varicose or stasis ulcers, are a consequence of damage to the valves in the veins of the legs, leading to raised venous pressure. Venous ulcers are characterised by a cyclical pattern of healing and recurrence. The main
- Dressings for superficial and partial thickness burns
Cochrane Systematic Reviews, 12-Feb-2013
An acute burn wound is a complex and evolving injury. Extensive burns produce systemic consequences, in addition to local tissue damage. Treatment of partial thickness burn wounds is directed towards promoting healing and a wide variety of dressings are c
- Dressings for the prevention of surgical site infection
Cochrane Systematic Reviews, 4-Aug-2015
Surgical wounds (incisions) heal by primary intention when the wound edges are brought together and secured - often with sutures, staples, clips or glue. Wound dressings, usually applied after wound closure, provide physical support, protection from bacte
- Dressings for treating foot ulcers in people with diabetes: an overview of systematic reviews
Cochrane Systematic Reviews, 7-Jul-2015
Foot ulcers in people with diabetes mellitus are a common and serious global health issue. Dressings form a key part of ulcer treatment, with clinicians and patients having many different types to choose from. A clear and current overview of current evide
- Driving assessment for maintaining mobility and safety in drivers with dementia
Cochrane Systematic Reviews, 21-Aug-2013
Demographic changes are leading to an increase in the number of older drivers: as dementia is an age-related disease, there is also an increase in the numbers of drivers with dementia. Dementia can impact on both the mobility and safety of drivers, and th
- Droperidol for acute psychosis
Cochrane Systematic Reviews, 3-May-2012
People suffering from acute psychotic illnesses, especially those associated with agitated or violent behaviour, may require urgent pharmacological tranquillisation or sedation. Droperidol, a butyrophenone neuroleptic, has been used for this purpose in se
- Droperidol for treatment of nausea and vomiting in palliative care patients
Cochrane Systematic Reviews, 27-Nov-2014
This is an updated version of the original Cochrane review published in Issue 10, 2010, on droperidol for the treatment of nausea and vomiting in palliative care patients. Nausea and vomiting are common symptoms in patients with terminal illness and can b
- Drug management for acute tonic-clonic convulsions including convulsive status epilepticus in children
Cochrane Systematic Reviews, 7-Sep-2010
Tonic-clonic (grand mal) convulsions and convulsive status epilepticus (currently defined as a grand mal convulsion lasting at least 30 minutes) are medical emergencies and demand urgent and appropriate anticonvulsant treatment. Benzodiazepines (midazolam
- Drug therapies for reducing gastric acidity in people with cystic fibrosis
Cochrane Systematic Reviews, 10-Jul-2014
Malabsorption of fat and protein contributes to poor nutritional status in people with cystic fibrosis. Impaired pancreatic function may also result in increased gastric acidity, leading in turn to heartburn, peptic ulcers and the impairment of oral pancr
- Drug therapy for chronic idiopathic axonal polyneuropathy
Cochrane Systematic Reviews, 3-Apr-2013
Chronic idiopathic axonal polyneuropathy is an insidiously progressive sensory or sensorimotor polyneuropathy that affects elderly people. Although severe disability or handicap does not occur, it reduces quality of life. This is an updated review.
- Drug therapy for delirium in terminally ill adult patients
Cochrane Systematic Reviews, 4-Oct-2012
Delirium is a syndrome characterised by a disturbance of consciousness (often fluctuating), cognition and perception. In terminally ill patients it is one of the most common causes of admission to clinical care. Delirium may arise from any number of cause
- Drug therapy for obstructive sleep apnoea in adults
Cochrane Systematic Reviews, 30-Apr-2013
The treatment of choice for moderate to severe obstructive sleep apnoea (OSA) is continuous positive airways pressure (CPAP) applied via a mask during sleep. However, this is not tolerated by all individuals and its role in mild OSA is not proven. Drug th
- Drug therapy for pain in amyotrophic lateral sclerosis or motor neuron disease
Cochrane Systematic Reviews, 22-May-2013
Amyotrophic lateral sclerosis (ALS), also known as motor neuron disease (MND), is the most common neurodegenerative disorder of the motor system in adults. Pain in ALS is a frequent symptom especially in the later stages of disease and can have a pronounc
- Drug therapy for preventing post-dural puncture headache
Cochrane Systematic Reviews, 25-Feb-2013
Post-dural (post-lumbar or post-spinal) puncture headache (PDPH) is one of the most common complications of diagnostic, therapeutic or inadvertent lumbar punctures. Many drug options have been used to prevent headache in clinical practice and have also be
- Drug therapy for symptoms associated with anxiety in adult palliative care patients
Cochrane Systematic Reviews, 5-Sep-2012
This is an update of the review published on 'Drug therapy for anxiety in adult palliative care patients' in Issue 1, 2004 of The Cochrane Library. Anxiety is common in palliative care patients. It can be a natural response to impending death, but it may
- Drug therapy for the management of cancer-related fatigue
Cochrane Systematic Reviews, 1-Aug-2010
This review is an update of a previously published review in The Cochrane Database of Systematic Reviews (Issue 1 2008). Cancer-related fatigue (CRF) is common, under-recognised and difficult to treat. There have been studies looking at drug interventions
- Drug therapy for treating post-dural puncture headache
Cochrane Systematic Reviews, 15-Jul-2015
This is an updated version of the original Cochrane review published in Issue 8, 2011, on 'Drug therapy for treating post-dural puncture headache'.
- Drug treatment for facioscapulohumeral muscular dystrophy
Cochrane Systematic Reviews, 11-Aug-2008
Facioscapulohumeral muscular dystrophy is a progressive muscle disease which has no agreed treatment. Early suggestions that corticosteroids might be helpful were not supported by a subsequent open label study. The beta 2 adrenergic agonist albuterol, als
- Drug treatment for faecal incontinence in adults
Cochrane Systematic Reviews, 11-Jun-2013
Faecal incontinence (leakage of bowel motions or stool) is a common symptom which causes significant distress and reduces quality of life.
- Drug treatment for myotonia
Cochrane Systematic Reviews, 10-May-2011
Abnormal delayed relaxation of skeletal muscles, known as myotonia, can cause disability in myotonic disorders. Sodium channel blockers, tricyclic antidepressive drugs, benzodiazepines, calcium-antagonists, taurine and prednisone may be of use in reducing
